Fennec Pharmaceuticals (FENC)

• Market cap: $224M
• 1 day: 3.67%
• 5 days: -1.96%
• 1 month: 12.48%
• 3 months: -14.49%
• 6 months: -22.09%
• Year to date: -15.49%
• 1 year: 7.45%
• 5 years: 3.84%
• 10 years: -45.92%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 35